New-Onset Diabetes After Liver Transplantation: From Pathogenesis to Management
Open Access
- 24 May 2005
- journal article
- review article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 11 (6) , 612-620
Abstract
New-onset diabetes mellitus (NODM) develops in approximately 15% of liver transplant recipients, and a similar proportion of patients have diabetes prior to transplantation. Preexisting diabetes and probably NODM are associated with increased mortality and risk of infection. NODM occurs more frequently among patients with hepatitis C infection; additional risk factors include family history, male gender, increasing weight, and alcoholic cirrhosis. Corticosteroid therapy, particularly bolus injections, increases likelihood of NODM, and randomized clinical trials and retrospective studies have shown NODM to occur more frequently with tacrolimus compared with cyclosporine. Patients undergoing liver transplantation should be screened for diabetes risk factors, and fasting plasma glucose should be monitored regularly in all transplant recipients. Management of NODM is essentially similar to that of diabetes in the nontransplant population, and includes dietary and lifestyle modifications. In choosing oral agents and/or insulin, the individual medical profile of the patient must be considered carefully. Corticosteroid exposure should be limited as much as possible, and reduction of calcineurin inhibitor dose is prudent. Switching from tacrolimus to cyclosporine may be required in some cases to achieve improvement or resolution. In conclusion, prospective trials are necessary to properly define antidiabetic therapy and immunosuppressive strategies in this population.Keywords
This publication has 58 references indexed in Scilit:
- New Onset Diabetes Mellitus in Patients Receiving Calcineurin Inhibitors: A Systematic Review and Meta-AnalysisAmerican Journal of Transplantation, 2004
- NEW-ONSET DIABETES AFTER TRANSPLANTATION: 2003 INTERNATIONAL CONSENSUS GUIDELINES1Transplantation, 2003
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2003
- Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitusLiver Transplantation, 2002
- Increased Risk of Type 2 Diabetes in Noncirrhotic Patients With Chronic Hepatitis C Virus InfectionMayo Clinic Proceedings, 2000
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Drug-Induced Disorders of Glucose MetabolismDrug Safety, 1996
- Diabetes mellitus after liver transplantation: prevalence and predictive factorsJournal of Hepatology, 1996
- Glucose metabolism in liver transplant recipients treated with FK 506 or cyclosporin in the European multicentre studyTransplant International, 1994
- DIABETOGENICITY OF FK506 VERSUS CYCLOSPORINE IN LIVER TRANSPLANT RECIPIENTSTransplantation, 1994